241 related articles for article (PubMed ID: 18684832)
1. Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.
Menotti L; Cerretani A; Hengel H; Campadelli-Fiume G
J Virol; 2008 Oct; 82(20):10153-61. PubMed ID: 18684832
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.
Leoni V; Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263255
[TBL] [Abstract][Full Text] [Related]
3. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.
Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
PLoS Pathog; 2017 Apr; 13(4):e1006352. PubMed ID: 28423057
[TBL] [Abstract][Full Text] [Related]
4. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
J Virol; 2017 May; 91(10):. PubMed ID: 28250120
[TBL] [Abstract][Full Text] [Related]
5. The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors.
Gatta V; Petrovic B; Campadelli-Fiume G
PLoS Pathog; 2015 May; 11(5):e1004907. PubMed ID: 25996983
[TBL] [Abstract][Full Text] [Related]
6. Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.
Petrovic B; Leoni V; Gatta V; Zaghini A; Vannini A; Campadelli-Fiume G
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263257
[TBL] [Abstract][Full Text] [Related]
7. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
Ikeda H; Uchida H; Okubo Y; Shibata T; Sasaki Y; Suzuki T; Hamada-Uematsu M; Hamasaki R; Okuda K; Yamaguchi M; Kojima M; Tanaka M; Hamada H; Tahara H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33627393
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
Menotti L; Nicoletti G; Gatta V; Croci S; Landuzzi L; De Giovanni C; Nanni P; Lollini PL; Campadelli-Fiume G
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9039-44. PubMed ID: 19458262
[TBL] [Abstract][Full Text] [Related]
9. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
10. The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2.
Cocchi F; Menotti L; Di Ninni V; Lopez M; Campadelli-Fiume G
J Virol; 2004 May; 78(9):4720-9. PubMed ID: 15078954
[TBL] [Abstract][Full Text] [Related]
11. A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors.
Menotti L; Cerretani A; Campadelli-Fiume G
J Virol; 2006 Jun; 80(11):5531-9. PubMed ID: 16699034
[TBL] [Abstract][Full Text] [Related]
12. Substitution in the murine nectin1 receptor of a single conserved amino acid at a position distal from the herpes simplex virus gD binding site confers high-affinity binding to gD.
Menotti L; Casadio R; Bertucci C; Lopez M; Campadelli-Fiume G
J Virol; 2002 Jun; 76(11):5463-71. PubMed ID: 11991974
[TBL] [Abstract][Full Text] [Related]
13. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
[TBL] [Abstract][Full Text] [Related]
14. Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry.
Cocchi F; Lopez M; Dubreuil P; Campadelli Fiume G; Menotti L
J Virol; 2001 Sep; 75(17):7987-94. PubMed ID: 11483743
[TBL] [Abstract][Full Text] [Related]
15. Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.
Baek H; Uchida H; Jun K; Kim JH; Kuroki M; Cohen JB; Glorioso JC; Kwon H
Mol Ther; 2011 Mar; 19(3):507-14. PubMed ID: 20924362
[TBL] [Abstract][Full Text] [Related]
16. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.
Uchida H; Shah WA; Ozuer A; Frampton AR; Goins WF; Grandi P; Cohen JB; Glorioso JC
J Virol; 2009 Apr; 83(7):2951-61. PubMed ID: 19129446
[TBL] [Abstract][Full Text] [Related]
17. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.
Menotti L; Avitabile E; Gatta V; Malatesta P; Petrovic B; Campadelli-Fiume G
Viruses; 2018 Jun; 10(7):. PubMed ID: 29966356
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
19. Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1.
Lazear E; Whitbeck JC; Zuo Y; Carfí A; Cohen GH; Eisenberg RJ; Krummenacher C
Virology; 2014 Jan; 448():185-95. PubMed ID: 24314649
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice.
Reisoli E; Gambini E; Appolloni I; Gatta V; Barilari M; Menotti L; Malatesta P
Cancer Gene Ther; 2012 Nov; 19(11):788-95. PubMed ID: 22996742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
